Furthermore, symptomatic and hormonal counterregulatory responses to hypoglycaemia were compared between icodec and glargine U100 in a subgroup analysis that only included individuals when they actually experienced hypoglycaemia after a double or triple dose of either insulin product. This evidence concerns the gene INS and Hypoglycemia.